Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery

• Status: Completed
• Trial end date: 2008-10-14
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare repeated intermittent IV dosing of diclofenac in patient with moderate to severe post-surgical pain from elective orthopedic surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Javelin Pharmaceuticals; Pfizer
• Treatments: Diclofenac; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• Scheduled within three weeks of the screening visit to undergo elective orthopedic surgery.

• Moderate to severe pain within 6 hours following completion of the required surgery.

Exclusion Criteria:

• Chronic pain conditions.

• Chronic disease or recent cardiovascular events.

• Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.